Global Ropivacaine Mesylate Supply, Demand and Key Producers, 2023-2029
The global Ropivacaine Mesylate market size is expected to reach $ 1357.2 million by 2029, rising at a market growth of 6.1% CAGR during the forecast period (2023-2029).
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup.
This report studies the global Ropivacaine Mesylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ropivacaine Mesylate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ropivacaine Mesylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ropivacaine Mesylate total production and demand, 2018-2029, (K Units)
Global Ropivacaine Mesylate total production value, 2018-2029, (USD Million)
Global Ropivacaine Mesylate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Ropivacaine Mesylate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Ropivacaine Mesylate domestic production, consumption, key domestic manufacturers and share
Global Ropivacaine Mesylate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Ropivacaine Mesylate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Ropivacaine Mesylate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Ropivacaine Mesylate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP and Zhejiang Xianju Pharmaceutical Co.,Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ropivacaine Mesylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Ropivacaine Mesylate Market, By Region:
1. How big is the global Ropivacaine Mesylate market?
2. What is the demand of the global Ropivacaine Mesylate market?
3. What is the year over year growth of the global Ropivacaine Mesylate market?
4. What is the production and production value of the global Ropivacaine Mesylate market?
5. Who are the key producers in the global Ropivacaine Mesylate market?
6. What are the growth factors driving the market demand?
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup.
This report studies the global Ropivacaine Mesylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ropivacaine Mesylate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ropivacaine Mesylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ropivacaine Mesylate total production and demand, 2018-2029, (K Units)
Global Ropivacaine Mesylate total production value, 2018-2029, (USD Million)
Global Ropivacaine Mesylate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Ropivacaine Mesylate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Ropivacaine Mesylate domestic production, consumption, key domestic manufacturers and share
Global Ropivacaine Mesylate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Ropivacaine Mesylate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Ropivacaine Mesylate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Ropivacaine Mesylate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP and Zhejiang Xianju Pharmaceutical Co.,Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ropivacaine Mesylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Ropivacaine Mesylate Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 2 mg/mL (0.2%)
- 5 mg/mL (0.5%)
- 7.5 mg/mL (0.75%)
- 10 mg/mL (1%)
- Surgical Anesthesia
- Major Nerve Block
- Acute Pain Management
- Other
- Pfizer
- Akorn
- Anant Pharmaceuticals
- SGPharma
- Nephron Pharmaceuticals
- Sintetica SA
- AstraZeneca
- Manus Aktteva Biopharma LLP
- Zhejiang Xianju Pharmaceutical Co.,Ltd
- Jiangsu Nhwa Pharmaceutical Co.,Ltd.
- Yangzi River Pharmaceutical Group
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Jiangsu Nhwa Pharmaceutical Co.,Ltd
1. How big is the global Ropivacaine Mesylate market?
2. What is the demand of the global Ropivacaine Mesylate market?
3. What is the year over year growth of the global Ropivacaine Mesylate market?
4. What is the production and production value of the global Ropivacaine Mesylate market?
5. Who are the key producers in the global Ropivacaine Mesylate market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Ropivacaine Mesylate Introduction
1.2 World Ropivacaine Mesylate Supply & Forecast
1.2.1 World Ropivacaine Mesylate Production Value (2018 & 2022 & 2029)
1.2.2 World Ropivacaine Mesylate Production (2018-2029)
1.2.3 World Ropivacaine Mesylate Pricing Trends (2018-2029)
1.3 World Ropivacaine Mesylate Production by Region (Based on Production Site)
1.3.1 World Ropivacaine Mesylate Production Value by Region (2018-2029)
1.3.2 World Ropivacaine Mesylate Production by Region (2018-2029)
1.3.3 World Ropivacaine Mesylate Average Price by Region (2018-2029)
1.3.4 North America Ropivacaine Mesylate Production (2018-2029)
1.3.5 Europe Ropivacaine Mesylate Production (2018-2029)
1.3.6 China Ropivacaine Mesylate Production (2018-2029)
1.3.7 Japan Ropivacaine Mesylate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ropivacaine Mesylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ropivacaine Mesylate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Ropivacaine Mesylate Demand (2018-2029)
2.2 World Ropivacaine Mesylate Consumption by Region
2.2.1 World Ropivacaine Mesylate Consumption by Region (2018-2023)
2.2.2 World Ropivacaine Mesylate Consumption Forecast by Region (2024-2029)
2.3 United States Ropivacaine Mesylate Consumption (2018-2029)
2.4 China Ropivacaine Mesylate Consumption (2018-2029)
2.5 Europe Ropivacaine Mesylate Consumption (2018-2029)
2.6 Japan Ropivacaine Mesylate Consumption (2018-2029)
2.7 South Korea Ropivacaine Mesylate Consumption (2018-2029)
2.8 ASEAN Ropivacaine Mesylate Consumption (2018-2029)
2.9 India Ropivacaine Mesylate Consumption (2018-2029)
3 WORLD ROPIVACAINE MESYLATE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ropivacaine Mesylate Production Value by Manufacturer (2018-2023)
3.2 World Ropivacaine Mesylate Production by Manufacturer (2018-2023)
3.3 World Ropivacaine Mesylate Average Price by Manufacturer (2018-2023)
3.4 Ropivacaine Mesylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ropivacaine Mesylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ropivacaine Mesylate in 2022
3.5.3 Global Concentration Ratios (CR8) for Ropivacaine Mesylate in 2022
3.6 Ropivacaine Mesylate Market: Overall Company Footprint Analysis
3.6.1 Ropivacaine Mesylate Market: Region Footprint
3.6.2 Ropivacaine Mesylate Market: Company Product Type Footprint
3.6.3 Ropivacaine Mesylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ropivacaine Mesylate Production Value Comparison
4.1.1 United States VS China: Ropivacaine Mesylate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Ropivacaine Mesylate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Ropivacaine Mesylate Production Comparison
4.2.1 United States VS China: Ropivacaine Mesylate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Ropivacaine Mesylate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Ropivacaine Mesylate Consumption Comparison
4.3.1 United States VS China: Ropivacaine Mesylate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Ropivacaine Mesylate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Ropivacaine Mesylate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
4.5 China Based Ropivacaine Mesylate Manufacturers and Market Share
4.5.1 China Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.5.3 China Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
4.6 Rest of World Based Ropivacaine Mesylate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Ropivacaine Mesylate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 2 mg/mL (0.2%)
5.2.2 5 mg/mL (0.5%)
5.2.3 7.5 mg/mL (0.75%)
5.2.4 10 mg/mL (1%)
5.3 Market Segment by Type
5.3.1 World Ropivacaine Mesylate Production by Type (2018-2029)
5.3.2 World Ropivacaine Mesylate Production Value by Type (2018-2029)
5.3.3 World Ropivacaine Mesylate Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ropivacaine Mesylate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Surgical Anesthesia
6.2.2 Major Nerve Block
6.2.3 Acute Pain Management
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Ropivacaine Mesylate Production by Application (2018-2029)
6.3.2 World Ropivacaine Mesylate Production Value by Application (2018-2029)
6.3.3 World Ropivacaine Mesylate Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Ropivacaine Mesylate Product and Services
7.1.4 Pfizer Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Akorn
7.2.1 Akorn Details
7.2.2 Akorn Major Business
7.2.3 Akorn Ropivacaine Mesylate Product and Services
7.2.4 Akorn Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Akorn Recent Developments/Updates
7.2.6 Akorn Competitive Strengths & Weaknesses
7.3 Anant Pharmaceuticals
7.3.1 Anant Pharmaceuticals Details
7.3.2 Anant Pharmaceuticals Major Business
7.3.3 Anant Pharmaceuticals Ropivacaine Mesylate Product and Services
7.3.4 Anant Pharmaceuticals Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Anant Pharmaceuticals Recent Developments/Updates
7.3.6 Anant Pharmaceuticals Competitive Strengths & Weaknesses
7.4 SGPharma
7.4.1 SGPharma Details
7.4.2 SGPharma Major Business
7.4.3 SGPharma Ropivacaine Mesylate Product and Services
7.4.4 SGPharma Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 SGPharma Recent Developments/Updates
7.4.6 SGPharma Competitive Strengths & Weaknesses
7.5 Nephron Pharmaceuticals
7.5.1 Nephron Pharmaceuticals Details
7.5.2 Nephron Pharmaceuticals Major Business
7.5.3 Nephron Pharmaceuticals Ropivacaine Mesylate Product and Services
7.5.4 Nephron Pharmaceuticals Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nephron Pharmaceuticals Recent Developments/Updates
7.5.6 Nephron Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Sintetica SA
7.6.1 Sintetica SA Details
7.6.2 Sintetica SA Major Business
7.6.3 Sintetica SA Ropivacaine Mesylate Product and Services
7.6.4 Sintetica SA Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sintetica SA Recent Developments/Updates
7.6.6 Sintetica SA Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Ropivacaine Mesylate Product and Services
7.7.4 AstraZeneca Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Manus Aktteva Biopharma LLP
7.8.1 Manus Aktteva Biopharma LLP Details
7.8.2 Manus Aktteva Biopharma LLP Major Business
7.8.3 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Product and Services
7.8.4 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
7.8.6 Manus Aktteva Biopharma LLP Competitive Strengths & Weaknesses
7.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
7.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
7.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
7.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
7.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
7.9.6 Zhejiang Xianju Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
7.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
7.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Details
7.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
7.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Product and Services
7.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.10.6 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Yangzi River Pharmaceutical Group
7.11.1 Yangzi River Pharmaceutical Group Details
7.11.2 Yangzi River Pharmaceutical Group Major Business
7.11.3 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Product and Services
7.11.4 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7.11.6 Yangzi River Pharmaceutical Group Competitive Strengths & Weaknesses
7.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
7.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
7.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Product and Services
7.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.12.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
7.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Details
7.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
7.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
7.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates
7.13.6 Jiangsu Nhwa Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ropivacaine Mesylate Industry Chain
8.2 Ropivacaine Mesylate Upstream Analysis
8.2.1 Ropivacaine Mesylate Core Raw Materials
8.2.2 Main Manufacturers of Ropivacaine Mesylate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ropivacaine Mesylate Production Mode
8.6 Ropivacaine Mesylate Procurement Model
8.7 Ropivacaine Mesylate Industry Sales Model and Sales Channels
8.7.1 Ropivacaine Mesylate Sales Model
8.7.2 Ropivacaine Mesylate Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Ropivacaine Mesylate Introduction
1.2 World Ropivacaine Mesylate Supply & Forecast
1.2.1 World Ropivacaine Mesylate Production Value (2018 & 2022 & 2029)
1.2.2 World Ropivacaine Mesylate Production (2018-2029)
1.2.3 World Ropivacaine Mesylate Pricing Trends (2018-2029)
1.3 World Ropivacaine Mesylate Production by Region (Based on Production Site)
1.3.1 World Ropivacaine Mesylate Production Value by Region (2018-2029)
1.3.2 World Ropivacaine Mesylate Production by Region (2018-2029)
1.3.3 World Ropivacaine Mesylate Average Price by Region (2018-2029)
1.3.4 North America Ropivacaine Mesylate Production (2018-2029)
1.3.5 Europe Ropivacaine Mesylate Production (2018-2029)
1.3.6 China Ropivacaine Mesylate Production (2018-2029)
1.3.7 Japan Ropivacaine Mesylate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ropivacaine Mesylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ropivacaine Mesylate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Ropivacaine Mesylate Demand (2018-2029)
2.2 World Ropivacaine Mesylate Consumption by Region
2.2.1 World Ropivacaine Mesylate Consumption by Region (2018-2023)
2.2.2 World Ropivacaine Mesylate Consumption Forecast by Region (2024-2029)
2.3 United States Ropivacaine Mesylate Consumption (2018-2029)
2.4 China Ropivacaine Mesylate Consumption (2018-2029)
2.5 Europe Ropivacaine Mesylate Consumption (2018-2029)
2.6 Japan Ropivacaine Mesylate Consumption (2018-2029)
2.7 South Korea Ropivacaine Mesylate Consumption (2018-2029)
2.8 ASEAN Ropivacaine Mesylate Consumption (2018-2029)
2.9 India Ropivacaine Mesylate Consumption (2018-2029)
3 WORLD ROPIVACAINE MESYLATE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ropivacaine Mesylate Production Value by Manufacturer (2018-2023)
3.2 World Ropivacaine Mesylate Production by Manufacturer (2018-2023)
3.3 World Ropivacaine Mesylate Average Price by Manufacturer (2018-2023)
3.4 Ropivacaine Mesylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ropivacaine Mesylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ropivacaine Mesylate in 2022
3.5.3 Global Concentration Ratios (CR8) for Ropivacaine Mesylate in 2022
3.6 Ropivacaine Mesylate Market: Overall Company Footprint Analysis
3.6.1 Ropivacaine Mesylate Market: Region Footprint
3.6.2 Ropivacaine Mesylate Market: Company Product Type Footprint
3.6.3 Ropivacaine Mesylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ropivacaine Mesylate Production Value Comparison
4.1.1 United States VS China: Ropivacaine Mesylate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Ropivacaine Mesylate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Ropivacaine Mesylate Production Comparison
4.2.1 United States VS China: Ropivacaine Mesylate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Ropivacaine Mesylate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Ropivacaine Mesylate Consumption Comparison
4.3.1 United States VS China: Ropivacaine Mesylate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Ropivacaine Mesylate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Ropivacaine Mesylate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
4.5 China Based Ropivacaine Mesylate Manufacturers and Market Share
4.5.1 China Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.5.3 China Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
4.6 Rest of World Based Ropivacaine Mesylate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ropivacaine Mesylate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Ropivacaine Mesylate Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Ropivacaine Mesylate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 2 mg/mL (0.2%)
5.2.2 5 mg/mL (0.5%)
5.2.3 7.5 mg/mL (0.75%)
5.2.4 10 mg/mL (1%)
5.3 Market Segment by Type
5.3.1 World Ropivacaine Mesylate Production by Type (2018-2029)
5.3.2 World Ropivacaine Mesylate Production Value by Type (2018-2029)
5.3.3 World Ropivacaine Mesylate Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ropivacaine Mesylate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Surgical Anesthesia
6.2.2 Major Nerve Block
6.2.3 Acute Pain Management
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Ropivacaine Mesylate Production by Application (2018-2029)
6.3.2 World Ropivacaine Mesylate Production Value by Application (2018-2029)
6.3.3 World Ropivacaine Mesylate Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Ropivacaine Mesylate Product and Services
7.1.4 Pfizer Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Akorn
7.2.1 Akorn Details
7.2.2 Akorn Major Business
7.2.3 Akorn Ropivacaine Mesylate Product and Services
7.2.4 Akorn Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Akorn Recent Developments/Updates
7.2.6 Akorn Competitive Strengths & Weaknesses
7.3 Anant Pharmaceuticals
7.3.1 Anant Pharmaceuticals Details
7.3.2 Anant Pharmaceuticals Major Business
7.3.3 Anant Pharmaceuticals Ropivacaine Mesylate Product and Services
7.3.4 Anant Pharmaceuticals Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Anant Pharmaceuticals Recent Developments/Updates
7.3.6 Anant Pharmaceuticals Competitive Strengths & Weaknesses
7.4 SGPharma
7.4.1 SGPharma Details
7.4.2 SGPharma Major Business
7.4.3 SGPharma Ropivacaine Mesylate Product and Services
7.4.4 SGPharma Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 SGPharma Recent Developments/Updates
7.4.6 SGPharma Competitive Strengths & Weaknesses
7.5 Nephron Pharmaceuticals
7.5.1 Nephron Pharmaceuticals Details
7.5.2 Nephron Pharmaceuticals Major Business
7.5.3 Nephron Pharmaceuticals Ropivacaine Mesylate Product and Services
7.5.4 Nephron Pharmaceuticals Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nephron Pharmaceuticals Recent Developments/Updates
7.5.6 Nephron Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Sintetica SA
7.6.1 Sintetica SA Details
7.6.2 Sintetica SA Major Business
7.6.3 Sintetica SA Ropivacaine Mesylate Product and Services
7.6.4 Sintetica SA Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sintetica SA Recent Developments/Updates
7.6.6 Sintetica SA Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Ropivacaine Mesylate Product and Services
7.7.4 AstraZeneca Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 Manus Aktteva Biopharma LLP
7.8.1 Manus Aktteva Biopharma LLP Details
7.8.2 Manus Aktteva Biopharma LLP Major Business
7.8.3 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Product and Services
7.8.4 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
7.8.6 Manus Aktteva Biopharma LLP Competitive Strengths & Weaknesses
7.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
7.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
7.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
7.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
7.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
7.9.6 Zhejiang Xianju Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
7.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
7.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Details
7.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
7.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Product and Services
7.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.10.6 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Yangzi River Pharmaceutical Group
7.11.1 Yangzi River Pharmaceutical Group Details
7.11.2 Yangzi River Pharmaceutical Group Major Business
7.11.3 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Product and Services
7.11.4 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7.11.6 Yangzi River Pharmaceutical Group Competitive Strengths & Weaknesses
7.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
7.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
7.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Product and Services
7.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.12.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
7.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Details
7.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
7.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
7.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates
7.13.6 Jiangsu Nhwa Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ropivacaine Mesylate Industry Chain
8.2 Ropivacaine Mesylate Upstream Analysis
8.2.1 Ropivacaine Mesylate Core Raw Materials
8.2.2 Main Manufacturers of Ropivacaine Mesylate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ropivacaine Mesylate Production Mode
8.6 Ropivacaine Mesylate Procurement Model
8.7 Ropivacaine Mesylate Industry Sales Model and Sales Channels
8.7.1 Ropivacaine Mesylate Sales Model
8.7.2 Ropivacaine Mesylate Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Ropivacaine Mesylate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Ropivacaine Mesylate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Ropivacaine Mesylate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Ropivacaine Mesylate Production Value Market Share by Region (2018-2023)
Table 5. World Ropivacaine Mesylate Production Value Market Share by Region (2024-2029)
Table 6. World Ropivacaine Mesylate Production by Region (2018-2023) & (K Units)
Table 7. World Ropivacaine Mesylate Production by Region (2024-2029) & (K Units)
Table 8. World Ropivacaine Mesylate Production Market Share by Region (2018-2023)
Table 9. World Ropivacaine Mesylate Production Market Share by Region (2024-2029)
Table 10. World Ropivacaine Mesylate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Ropivacaine Mesylate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Ropivacaine Mesylate Major Market Trends
Table 13. World Ropivacaine Mesylate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Ropivacaine Mesylate Consumption by Region (2018-2023) & (K Units)
Table 15. World Ropivacaine Mesylate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Ropivacaine Mesylate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Ropivacaine Mesylate Producers in 2022
Table 18. World Ropivacaine Mesylate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Ropivacaine Mesylate Producers in 2022
Table 20. World Ropivacaine Mesylate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Ropivacaine Mesylate Company Evaluation Quadrant
Table 22. World Ropivacaine Mesylate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Ropivacaine Mesylate Production Site of Key Manufacturer
Table 24. Ropivacaine Mesylate Market: Company Product Type Footprint
Table 25. Ropivacaine Mesylate Market: Company Product Application Footprint
Table 26. Ropivacaine Mesylate Competitive Factors
Table 27. Ropivacaine Mesylate New Entrant and Capacity Expansion Plans
Table 28. Ropivacaine Mesylate Mergers & Acquisitions Activity
Table 29. United States VS China Ropivacaine Mesylate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Ropivacaine Mesylate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Ropivacaine Mesylate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 37. China Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 42. Rest of World Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 47. World Ropivacaine Mesylate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Ropivacaine Mesylate Production by Type (2018-2023) & (K Units)
Table 49. World Ropivacaine Mesylate Production by Type (2024-2029) & (K Units)
Table 50. World Ropivacaine Mesylate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Ropivacaine Mesylate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Ropivacaine Mesylate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Ropivacaine Mesylate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Ropivacaine Mesylate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Ropivacaine Mesylate Production by Application (2018-2023) & (K Units)
Table 56. World Ropivacaine Mesylate Production by Application (2024-2029) & (K Units)
Table 57. World Ropivacaine Mesylate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Ropivacaine Mesylate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Ropivacaine Mesylate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Ropivacaine Mesylate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Ropivacaine Mesylate Product and Services
Table 64. Pfizer Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Akorn Basic Information, Manufacturing Base and Competitors
Table 68. Akorn Major Business
Table 69. Akorn Ropivacaine Mesylate Product and Services
Table 70. Akorn Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Akorn Recent Developments/Updates
Table 72. Akorn Competitive Strengths & Weaknesses
Table 73. Anant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Anant Pharmaceuticals Major Business
Table 75. Anant Pharmaceuticals Ropivacaine Mesylate Product and Services
Table 76. Anant Pharmaceuticals Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Anant Pharmaceuticals Recent Developments/Updates
Table 78. Anant Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. SGPharma Basic Information, Manufacturing Base and Competitors
Table 80. SGPharma Major Business
Table 81. SGPharma Ropivacaine Mesylate Product and Services
Table 82. SGPharma Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. SGPharma Recent Developments/Updates
Table 84. SGPharma Competitive Strengths & Weaknesses
Table 85. Nephron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Nephron Pharmaceuticals Major Business
Table 87. Nephron Pharmaceuticals Ropivacaine Mesylate Product and Services
Table 88. Nephron Pharmaceuticals Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nephron Pharmaceuticals Recent Developments/Updates
Table 90. Nephron Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Sintetica SA Basic Information, Manufacturing Base and Competitors
Table 92. Sintetica SA Major Business
Table 93. Sintetica SA Ropivacaine Mesylate Product and Services
Table 94. Sintetica SA Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sintetica SA Recent Developments/Updates
Table 96. Sintetica SA Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca Ropivacaine Mesylate Product and Services
Table 100. AstraZeneca Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 104. Manus Aktteva Biopharma LLP Major Business
Table 105. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Product and Services
Table 106. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 108. Manus Aktteva Biopharma LLP Competitive Strengths & Weaknesses
Table 109. Zhejiang Xianju Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
Table 111. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
Table 112. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 114. Zhejiang Xianju Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
Table 115. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
Table 117. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Product and Services
Table 118. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 120. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 121. Yangzi River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 122. Yangzi River Pharmaceutical Group Major Business
Table 123. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Product and Services
Table 124. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Yangzi River Pharmaceutical Group Recent Developments/Updates
Table 126. Yangzi River Pharmaceutical Group Competitive Strengths & Weaknesses
Table 127. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 129. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Product and Services
Table 130. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 132. Jiangsu Nhwa Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 133. Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
Table 134. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
Table 135. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Ropivacaine Mesylate Upstream (Raw Materials)
Table 137. Ropivacaine Mesylate Typical Customers
Table 138. Ropivacaine Mesylate Typical Distributors
Table 1. World Ropivacaine Mesylate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Ropivacaine Mesylate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Ropivacaine Mesylate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Ropivacaine Mesylate Production Value Market Share by Region (2018-2023)
Table 5. World Ropivacaine Mesylate Production Value Market Share by Region (2024-2029)
Table 6. World Ropivacaine Mesylate Production by Region (2018-2023) & (K Units)
Table 7. World Ropivacaine Mesylate Production by Region (2024-2029) & (K Units)
Table 8. World Ropivacaine Mesylate Production Market Share by Region (2018-2023)
Table 9. World Ropivacaine Mesylate Production Market Share by Region (2024-2029)
Table 10. World Ropivacaine Mesylate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Ropivacaine Mesylate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Ropivacaine Mesylate Major Market Trends
Table 13. World Ropivacaine Mesylate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Ropivacaine Mesylate Consumption by Region (2018-2023) & (K Units)
Table 15. World Ropivacaine Mesylate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Ropivacaine Mesylate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Ropivacaine Mesylate Producers in 2022
Table 18. World Ropivacaine Mesylate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Ropivacaine Mesylate Producers in 2022
Table 20. World Ropivacaine Mesylate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Ropivacaine Mesylate Company Evaluation Quadrant
Table 22. World Ropivacaine Mesylate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Ropivacaine Mesylate Production Site of Key Manufacturer
Table 24. Ropivacaine Mesylate Market: Company Product Type Footprint
Table 25. Ropivacaine Mesylate Market: Company Product Application Footprint
Table 26. Ropivacaine Mesylate Competitive Factors
Table 27. Ropivacaine Mesylate New Entrant and Capacity Expansion Plans
Table 28. Ropivacaine Mesylate Mergers & Acquisitions Activity
Table 29. United States VS China Ropivacaine Mesylate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Ropivacaine Mesylate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Ropivacaine Mesylate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 37. China Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 42. Rest of World Based Ropivacaine Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Ropivacaine Mesylate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Ropivacaine Mesylate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Ropivacaine Mesylate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Ropivacaine Mesylate Production Market Share (2018-2023)
Table 47. World Ropivacaine Mesylate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Ropivacaine Mesylate Production by Type (2018-2023) & (K Units)
Table 49. World Ropivacaine Mesylate Production by Type (2024-2029) & (K Units)
Table 50. World Ropivacaine Mesylate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Ropivacaine Mesylate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Ropivacaine Mesylate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Ropivacaine Mesylate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Ropivacaine Mesylate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Ropivacaine Mesylate Production by Application (2018-2023) & (K Units)
Table 56. World Ropivacaine Mesylate Production by Application (2024-2029) & (K Units)
Table 57. World Ropivacaine Mesylate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Ropivacaine Mesylate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Ropivacaine Mesylate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Ropivacaine Mesylate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Ropivacaine Mesylate Product and Services
Table 64. Pfizer Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Akorn Basic Information, Manufacturing Base and Competitors
Table 68. Akorn Major Business
Table 69. Akorn Ropivacaine Mesylate Product and Services
Table 70. Akorn Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Akorn Recent Developments/Updates
Table 72. Akorn Competitive Strengths & Weaknesses
Table 73. Anant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Anant Pharmaceuticals Major Business
Table 75. Anant Pharmaceuticals Ropivacaine Mesylate Product and Services
Table 76. Anant Pharmaceuticals Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Anant Pharmaceuticals Recent Developments/Updates
Table 78. Anant Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. SGPharma Basic Information, Manufacturing Base and Competitors
Table 80. SGPharma Major Business
Table 81. SGPharma Ropivacaine Mesylate Product and Services
Table 82. SGPharma Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. SGPharma Recent Developments/Updates
Table 84. SGPharma Competitive Strengths & Weaknesses
Table 85. Nephron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Nephron Pharmaceuticals Major Business
Table 87. Nephron Pharmaceuticals Ropivacaine Mesylate Product and Services
Table 88. Nephron Pharmaceuticals Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nephron Pharmaceuticals Recent Developments/Updates
Table 90. Nephron Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Sintetica SA Basic Information, Manufacturing Base and Competitors
Table 92. Sintetica SA Major Business
Table 93. Sintetica SA Ropivacaine Mesylate Product and Services
Table 94. Sintetica SA Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sintetica SA Recent Developments/Updates
Table 96. Sintetica SA Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca Ropivacaine Mesylate Product and Services
Table 100. AstraZeneca Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 104. Manus Aktteva Biopharma LLP Major Business
Table 105. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Product and Services
Table 106. Manus Aktteva Biopharma LLP Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 108. Manus Aktteva Biopharma LLP Competitive Strengths & Weaknesses
Table 109. Zhejiang Xianju Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
Table 111. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
Table 112. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 114. Zhejiang Xianju Pharmaceutical Co.,Ltd Competitive Strengths & Weaknesses
Table 115. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
Table 117. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Product and Services
Table 118. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 120. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 121. Yangzi River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 122. Yangzi River Pharmaceutical Group Major Business
Table 123. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Product and Services
Table 124. Yangzi River Pharmaceutical Group Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Yangzi River Pharmaceutical Group Recent Developments/Updates
Table 126. Yangzi River Pharmaceutical Group Competitive Strengths & Weaknesses
Table 127. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 129. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Product and Services
Table 130. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 132. Jiangsu Nhwa Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 133. Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
Table 134. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
Table 135. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Ropivacaine Mesylate Upstream (Raw Materials)
Table 137. Ropivacaine Mesylate Typical Customers
Table 138. Ropivacaine Mesylate Typical Distributors
LIST OF FIGURES
Figure 1. Ropivacaine Mesylate Picture
Figure 2. World Ropivacaine Mesylate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Ropivacaine Mesylate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 5. World Ropivacaine Mesylate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Ropivacaine Mesylate Production Value Market Share by Region (2018-2029)
Figure 7. World Ropivacaine Mesylate Production Market Share by Region (2018-2029)
Figure 8. North America Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 9. Europe Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 10. China Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 11. Japan Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 12. Ropivacaine Mesylate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 15. World Ropivacaine Mesylate Consumption Market Share by Region (2018-2029)
Figure 16. United States Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 17. China Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 18. Europe Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 19. Japan Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 22. India Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Ropivacaine Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ropivacaine Mesylate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ropivacaine Mesylate Markets in 2022
Figure 26. United States VS China: Ropivacaine Mesylate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Ropivacaine Mesylate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Ropivacaine Mesylate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 30. China Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 32. World Ropivacaine Mesylate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Ropivacaine Mesylate Production Value Market Share by Type in 2022
Figure 34. 2 mg/mL (0.2%)
Figure 35. 5 mg/mL (0.5%)
Figure 36. 7.5 mg/mL (0.75%)
Figure 37. 10 mg/mL (1%)
Figure 38. World Ropivacaine Mesylate Production Market Share by Type (2018-2029)
Figure 39. World Ropivacaine Mesylate Production Value Market Share by Type (2018-2029)
Figure 40. World Ropivacaine Mesylate Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Ropivacaine Mesylate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Ropivacaine Mesylate Production Value Market Share by Application in 2022
Figure 43. Surgical Anesthesia
Figure 44. Major Nerve Block
Figure 45. Acute Pain Management
Figure 46. Other
Figure 47. World Ropivacaine Mesylate Production Market Share by Application (2018-2029)
Figure 48. World Ropivacaine Mesylate Production Value Market Share by Application (2018-2029)
Figure 49. World Ropivacaine Mesylate Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Ropivacaine Mesylate Industry Chain
Figure 51. Ropivacaine Mesylate Procurement Model
Figure 52. Ropivacaine Mesylate Sales Model
Figure 53. Ropivacaine Mesylate Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Ropivacaine Mesylate Picture
Figure 2. World Ropivacaine Mesylate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Ropivacaine Mesylate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 5. World Ropivacaine Mesylate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Ropivacaine Mesylate Production Value Market Share by Region (2018-2029)
Figure 7. World Ropivacaine Mesylate Production Market Share by Region (2018-2029)
Figure 8. North America Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 9. Europe Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 10. China Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 11. Japan Ropivacaine Mesylate Production (2018-2029) & (K Units)
Figure 12. Ropivacaine Mesylate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 15. World Ropivacaine Mesylate Consumption Market Share by Region (2018-2029)
Figure 16. United States Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 17. China Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 18. Europe Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 19. Japan Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 22. India Ropivacaine Mesylate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Ropivacaine Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ropivacaine Mesylate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ropivacaine Mesylate Markets in 2022
Figure 26. United States VS China: Ropivacaine Mesylate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Ropivacaine Mesylate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Ropivacaine Mesylate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 30. China Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Ropivacaine Mesylate Production Market Share 2022
Figure 32. World Ropivacaine Mesylate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Ropivacaine Mesylate Production Value Market Share by Type in 2022
Figure 34. 2 mg/mL (0.2%)
Figure 35. 5 mg/mL (0.5%)
Figure 36. 7.5 mg/mL (0.75%)
Figure 37. 10 mg/mL (1%)
Figure 38. World Ropivacaine Mesylate Production Market Share by Type (2018-2029)
Figure 39. World Ropivacaine Mesylate Production Value Market Share by Type (2018-2029)
Figure 40. World Ropivacaine Mesylate Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Ropivacaine Mesylate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Ropivacaine Mesylate Production Value Market Share by Application in 2022
Figure 43. Surgical Anesthesia
Figure 44. Major Nerve Block
Figure 45. Acute Pain Management
Figure 46. Other
Figure 47. World Ropivacaine Mesylate Production Market Share by Application (2018-2029)
Figure 48. World Ropivacaine Mesylate Production Value Market Share by Application (2018-2029)
Figure 49. World Ropivacaine Mesylate Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Ropivacaine Mesylate Industry Chain
Figure 51. Ropivacaine Mesylate Procurement Model
Figure 52. Ropivacaine Mesylate Sales Model
Figure 53. Ropivacaine Mesylate Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
